Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Change in Acquisitions & Divestments (2016 - 2025)

Neurocrine Biosciences' Change in Acquisitions & Divestments history spans 16 years, with the latest figure at $267.7 million for Q4 2025.

  • For Q4 2025, Change in Acquisitions & Divestments rose 6.74% year-over-year to $267.7 million; the TTM value through Dec 2025 reached $1.1 billion, up 12.6%, while the annual FY2025 figure was $1.1 billion, 12.6% up from the prior year.
  • Change in Acquisitions & Divestments reached $267.7 million in Q4 2025 per NBIX's latest filing, up from $225.0 million in the prior quarter.
  • In the past five years, Change in Acquisitions & Divestments ranged from a high of $298.6 million in Q2 2025 to a low of $71.2 million in Q3 2022.
  • Average Change in Acquisitions & Divestments over 5 years is $211.9 million, with a median of $204.3 million recorded in 2023.
  • Peak YoY movement for Change in Acquisitions & Divestments: plummeted 55.42% in 2022, then skyrocketed 283.43% in 2023.
  • A 5-year view of Change in Acquisitions & Divestments shows it stood at $174.0 million in 2021, then fell by 6.78% to $162.2 million in 2022, then soared by 79.28% to $290.8 million in 2023, then decreased by 13.76% to $250.8 million in 2024, then grew by 6.74% to $267.7 million in 2025.
  • Per Business Quant, the three most recent readings for NBIX's Change in Acquisitions & Divestments are $267.7 million (Q4 2025), $225.0 million (Q3 2025), and $298.6 million (Q2 2025).